Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (1617)
All Articles published online
|
Mar 21, 2007 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Jin X, Yu CH, Lv GC, Li YM. Increased intestinal permeability in pathogenesis and progress of nonalcoholic steatohepatitis in rats. World J Gastroenterol 2007; 13(11): 1732-1736 [PMID: 17461479 DOI: 10.3748/wjg.v13.i11.1732] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i11/1732.htm |
| Number | Citing Articles |
| 1 |
Feifei Han, Hanxue Fan, Ming Yao, Shasha Yang, Jianzhong Han. Oral administration of yeast β-glucan ameliorates inflammation and intestinal barrier in dextran sodium sulfate-induced acute colitis. Journal of Functional Foods 2017; 35: 115 doi: 10.1016/j.jff.2017.05.036
|
| 2 |
Zhenlong Luo, Yudong Ji, Hong Gao, Felipe Castellani Gomes Dos Reis, Gautam Bandyopadhyay, Zhongmou Jin, Crystal Ly, Ya-ju Chang, Dinghong Zhang, Deepak Kumar, Wei Ying. CRIg+ Macrophages Prevent Gut Microbial DNA–Containing Extracellular Vesicle–Induced Tissue Inflammation and Insulin Resistance. Gastroenterology 2021; 160(3): 863 doi: 10.1053/j.gastro.2020.10.042
|
| 3 |
Xi Jin, Yi‐peng Chen, Mei Kong, Lin Zheng, Yi‐da Yang, You‐ming Li. Transition from hepatic steatosis to steatohepatitis: Unique microRNA patterns and potential downstream functions and pathways. Journal of Gastroenterology and Hepatology 2012; 27(2): 331 doi: 10.1111/j.1440-1746.2011.06864.x
|
| 4 |
X. Jin, Y.-F. Ye, S.-H. Chen, C.-H. Yu, J. Liu, Y.-M. Li. MicroRNA expression pattern in different stages of nonalcoholic fatty liver disease. Digestive and Liver Disease 2009; 41(4): 289 doi: 10.1016/j.dld.2008.08.008
|
| 5 |
Marcin Krawczyk, Leonilde Bonfrate, Piero Portincasa. Nonalcoholic fatty liver disease. Best Practice & Research Clinical Gastroenterology 2010; 24(5): 695 doi: 10.1016/j.bpg.2010.08.005
|
| 6 |
Yinhua Ni, Liyang Ni, Fen Zhuge, Zhengwei Fu. The Gut Microbiota and Its Metabolites, Novel Targets for Treating and Preventing Non‐Alcoholic Fatty Liver Disease. Molecular Nutrition & Food Research 2020; 64(17) doi: 10.1002/mnfr.202000375
|
| 7 |
Linghan Kuang, Wei Zhou, Yongmei Jiang, Nikhil Pai. Association of small intestinal bacterial overgrowth with nonalcoholic fatty liver disease in children: A meta-analysis. PLOS ONE 2021; 16(12): e0260479 doi: 10.1371/journal.pone.0260479
|
| 8 |
Ahmed Abu Shanab, Paul Scully, Orla Crosbie, Martin Buckley, Liam O’Mahony, Fergus Shanahan, Sanaa Gazareen, Eileen Murphy, Eamonn M. M. Quigley. Small Intestinal Bacterial Overgrowth in Nonalcoholic Steatohepatitis: Association with Toll-Like Receptor 4 Expression and Plasma Levels of Interleukin 8. Digestive Diseases and Sciences 2011; 56(5): 1524 doi: 10.1007/s10620-010-1447-3
|
| 9 |
Qianrong Wang, Xiangning Tang, Yu Wang, Danyi Zhang, Xia Li, Shanshan Liu. The role of extracellular vesicles in non-alcoholic steatohepatitis: Emerging mechanisms, potential therapeutics and biomarkers. Journal of Advanced Research 2024; doi: 10.1016/j.jare.2024.03.009
|
| 10 |
Kirsten E. Pijls, Daisy M. A. E. Jonkers, Elhaseen E. Elamin, Ad A. M. Masclee, Ger H. Koek. Intestinal epithelial barrier function in liver cirrhosis: an extensive review of the literature. Liver International 2013; 33(10): 1457 doi: 10.1111/liv.12271
|
| 11 |
Feifei Han, Xia Zhao, Xiang Li, Liyuan Peng, Weilin Liu, Jianzhong Han. Bovine lactoferricin ameliorates intestinal inflammation and mucosal barrier lesions in colitis through NF-κB/NLRP3 signaling pathways. Journal of Functional Foods 2022; 93: 105090 doi: 10.1016/j.jff.2022.105090
|
| 12 |
Muhammad Ashfaq-Khan, Misbah Aslam, Muhammad Asif Qureshi, Marcel Sascha Senkowski, Shih Yen-Weng, Susanne Strand, Yong Ook Kim, Geethanjali Pickert, Jörn M. Schattenberg, Detlef Schuppan. Dietary wheat amylase trypsin inhibitors promote features of murine non-alcoholic fatty liver disease. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-53323-x
|
| 13 |
Enrico Gugliandolo, Marika Cordaro, Rosalba Siracusa, Ramona D’Amico, Alessio Filippo Peritore, Tiziana Genovese, Daniela Impellizzeri, Rosanna Di Paola, Rosalia Crupi, Salvatore Cuzzocrea, Roberta Fusco. Novel Combination of COX-2 Inhibitor and Antioxidant Therapy for Modulating Oxidative Stress Associated with Intestinal Ischemic Reperfusion Injury and Endotoxemia. Antioxidants 2020; 9(10): 930 doi: 10.3390/antiox9100930
|
| 14 |
Sufang Chen, Xiang Li, Yanling Wang, Panwei Mu, Chaojin Chen, Pinjie Huang, Dezhao Liu. Ginsenoside Rb1 attenuates intestinal ischemia/reperfusion‑induced inflammation and oxidative stress via activation of the PI3K/Akt/Nrf2 signaling pathway. Molecular Medicine Reports 2019; doi: 10.3892/mmr.2019.10018
|
| 15 |
Cao Li, Ping Xiao, Da Lin, Hao-Jie Zhong, Ran Zhang, Zhi-gang Zhao, Xing-Xiang He. Risk Factors for Intestinal Barrier Impairment in Patients With Essential Hypertension. Frontiers in Medicine 2021; 7 doi: 10.3389/fmed.2020.543698
|
| 16 |
Ivanildo Coutinho de Medeiros, Josivan Gomes de Lima. Is nonalcoholic fatty liver disease an endogenous alcoholic fatty liver disease? – A mechanistic hypothesis. Medical Hypotheses 2015; 85(2): 148 doi: 10.1016/j.mehy.2015.04.021
|
| 17 |
X. J. Xu, Y. L. Zhang, L. Liu, L. Pan, S. K. Yao. Increased expression of nerve growth factor correlates with visceral hypersensitivity and impaired gut barrier function in diarrhoea‐predominant irritable bowel syndrome: a preliminary explorative study. Alimentary Pharmacology & Therapeutics 2017; 45(1): 100 doi: 10.1111/apt.13848
|
| 18 |
Piero Portincasa, Leonilde Bonfrate, Mohamad Khalil, Maria De Angelis, Francesco Maria Calabrese, Mauro D’Amato, David Q.-H. Wang, Agostino Di Ciaula. Intestinal Barrier and Permeability in Health, Obesity and NAFLD. Biomedicines 2021; 10(1): 83 doi: 10.3390/biomedicines10010083
|
| 19 |
Hong Gao, Zhongmou Jin, Kechun Tang, Yudong Ji, Jorge Suarez, Jorge A. Suarez, Karina Cunha e Rocha, Dinghong Zhang, Wolfgang H. Dillmann, Sushil K. Mahata, Wei Ying. Microbial DNA Enrichment Promotes Adrenomedullary Inflammation, Catecholamine Secretion, and Hypertension in Obese Mice. Journal of the American Heart Association 2022; 11(4) doi: 10.1161/JAHA.121.024561
|
| 20 |
Karn Wijarnpreecha, Susan Lou, Kanramon Watthanasuntorn, Paul T. Kroner, Wisit Cheungpasitporn, Frank J. Lukens, Surakit Pungpapong, Andrew P. Keaveny, Patompong Ungprasert. Small intestinal bacterial overgrowth and nonalcoholic fatty liver disease: a systematic review and meta-analysis. European Journal of Gastroenterology & Hepatology 2020; 32(5): 601 doi: 10.1097/MEG.0000000000001541
|
| 21 |
György Baffy. Kupffer cells in non-alcoholic fatty liver disease: The emerging view. Journal of Hepatology 2009; 51(1): 212 doi: 10.1016/j.jhep.2009.03.008
|
| 22 |
X. J. Xu, S. K. Yao. Editorial: increased expression of nerve growth factor correlates with visceral hypersensitivity and impaired gut barrier function in diarrhoea-predominant irritable bowel syndrome. Authors' reply. Alimentary Pharmacology & Therapeutics 2017; 45(4): 568 doi: 10.1111/apt.13916
|
| 23 |
Li Zhang, Yuanshang Wang, Ying Sun, Xin Zhang. Intermittent Fasting and Physical Exercise for Preventing Metabolic Disorders through Interaction with Gut Microbiota: A Review. Nutrients 2023; 15(10): 2277 doi: 10.3390/nu15102277
|
| 24 |
Jing Leng, Fu Huang, Yamei Hai, Huajie Tian, Wei Liu, Yi Fang, Yiyang Hu, Jinghua Peng. Amelioration of non-alcoholic steatohepatitis by Qushi Huayu decoction is associated with inhibition of the intestinal mitogen-activated protein kinase pathway. Phytomedicine 2020; 66: 153135 doi: 10.1016/j.phymed.2019.153135
|
| 25 |
Zhenlong Luo, Yudong Ji, Dinghong Zhang, Hong Gao, Zhongmou Jin, Meixiang Yang, Wei Ying. Microbial DNA enrichment promotes liver steatosis and fibrosis in the course of non‐alcoholic steatohepatitis. Acta Physiologica 2022; 235(3) doi: 10.1111/apha.13827
|
| 26 |
Xiao‐Hui Min, Tao Yu, Qing Qing, Yu‐Hong Yuan, Wa Zhong, Guang‐Cheng Chen, Li‐Na Zhao, Na Deng, Li‐Fa Zhang, Qi‐Kui Chen. Abnormal differentiation of intestinal epithelium and intestinal barrier dysfunction in diabetic mice associated with depressed Notch/NICD transduction in Notch/Hes1 signal pathway. Cell Biology International 2014; 38(10): 1194 doi: 10.1002/cbin.10323
|
| 27 |
Mulalibike Heizati, Nanfang Li, Liang Shao, Xiaoguang Yao, Yingchun Wang, Jing Hong, Ling Zhou, Delian Zhang, Guijuan Chang, Suofeiya Abulikemu. Does increased serum d-lactate mean subclinical hyperpermeability of intestinal barrier in middle-aged nonobese males with OSA?. Medicine 2017; 96(49): e9144 doi: 10.1097/MD.0000000000009144
|
| 28 |
Agostino Di Ciaula, Jacek Baj, Gabriella Garruti, Giuseppe Celano, Maria De Angelis, Helen H. Wang, Domenica Maria Di Palo, Leonilde Bonfrate, David Q-H Wang, Piero Portincasa. Liver Steatosis, Gut-Liver Axis, Microbiome and Environmental Factors. A Never-Ending Bidirectional Cross-Talk. Journal of Clinical Medicine 2020; 9(8): 2648 doi: 10.3390/jcm9082648
|
| 29 |
Xi Jin, Yi-da Yang, Kun Chen, Zhi-yuan Lv, Lin Zheng, Ya-ping Liu, Shao-hua Chen, Chao-hui Yu, Xue-yuan Jiang, Cheng-yu Zhang, You-ming Li. HDMCP uncouples yeast mitochondrial respiration and alleviates steatosis in L02 and hepG2 cells by decreasing ATP and H2O2 levels: A novel mechanism for NAFLD. Journal of Hepatology 2009; 50(5): 1019 doi: 10.1016/j.jhep.2008.10.034
|
| 30 |
Ren-ying Xu, Yan-ping Wan, Qi-yu Fang, Wei Lu, Wei Cai. Supplementation with probiotics modifies gut flora and attenuates liver fat accumulation in rat nonalcoholic fatty liver disease model. Journal of Clinical Biochemistry and Nutrition 2011; 50(1): 72 doi: 10.3164/jcbn.11-38
|
| 31 |
Feifei Han, Zeqing Lu, Yifan Liu, Xi Xia, Haiwen Zhang, Xinxia Wang, Yizhen Wang. Cathelicidin-BF ameliorates lipopolysaccharide-induced intestinal epithelial barrier disruption in rat. Life Sciences 2016; 152: 199 doi: 10.1016/j.lfs.2016.03.041
|
| 32 |
Chantal A. Rivera. Risk factors and mechanisms of non-alcoholic steatohepatitis. Pathophysiology 2008; 15(2): 109 doi: 10.1016/j.pathophys.2008.04.003
|
| 33 |
Li‐Li Zhang, Xiao Chen, Peng‐Yuan Zheng, Yu Luo, Gao‐Feng Lu, Zhi‐Qiang Liu, Huang Huang, Ping‐Chang Yang. Oral Bifidobacterium modulates intestinal immune inflammation in mice with food allergy. Journal of Gastroenterology and Hepatology 2010; 25(5): 928 doi: 10.1111/j.1440-1746.2009.06193.x
|
| 34 |
Herbert Tilg, Niv Zmora, Timon E. Adolph, Eran Elinav. The intestinal microbiota fuelling metabolic inflammation. Nature Reviews Immunology 2020; 20(1): 40 doi: 10.1038/s41577-019-0198-4
|